Plain-English translation of NCT07219472 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This study is testing Scrambler Therapy, a non-medication device that uses electrical signals to help reduce nerve pain and numbness caused by chemotherapy. The device works by sending signals through electrodes placed on your skin to help your nervous system perceive pain differently. Researchers want to see if this treatment can provide real relief and improve quality of life for people dealing with this type of pain.
Nerve pain and numbness after chemotherapy (called CIPN) affects 30–40% of cancer patients and often doesn't go away for a long time, making daily life difficult. Most current treatments use medications, which may have side effects, so this trial is testing whether this medication-free device could be a better option for patients who want an alternative.
You likely qualify if…
You likely don't qualify if…
You will be randomly assigned to receive either real Scrambler Therapy or a sham (fake) version. The real treatment involves ten sessions over two weeks, where electrodes are placed on your skin and the device sends electrical signals to help reduce pain perception. You'll complete questionnaires before, during, and after treatment to track how your pain and quality of life change. The entire study follows you for a period to measure both short-term and long-term effects.
AI-generated summary from trial data · Jun 7, 2026 · Not medical advice
United States